久久久久国产综合AV天堂_亚洲日韩精品一区二区三区_99精品丰满人妻无码一区二区_里番本子纯肉侵犯肉全彩无码_亚洲国产精品一区二区久久_综合三区后入内射国产馆_99精品视频免费热播在线观看_97国产精品视频在线观看_亚洲国产色播av在线_玩弄人妻奶水无码AV在线

Ensysce Biosciences Inc. efforts in the development of the single walled carbon nanotube (SWCNT) delivery platform for therapeutic applications has led to the important finding that SWCNT can transfect peripheral blood mononuclear cells (PBMCs) following intravenous administration.

Ensysce has data demonstrating that SWCNT form stable complexes with oligonucleotide payloads, including full length RNA and plasmid DNA. These SWCNT complexes facilitate the delivery of large biologically active agents through natural barriers within the body, and readily into PBMC. Ensysce has also shown the complexes can be formulated to control relative tissue distribution following intravenous administration.

Oligonucleotide delivery especially to PBMCs has been a focus of intense research for years and as seen with the CART therapy is currently limited to in vitro methods using viral vectors or mechanical electroporation. The ability of SWCNT to enable in vivo transfection of PBMCs would be a significant accomplishment for this field which may lead to novel therapeutic approaches for the CART and crisper technologies.